Lexston Life Sciences Corp. (LEXT) AI Stock Analysis

• Market Cap: C$2.85M
• Dividend Yield: N/A
• Average Volume (3M): 30.44K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.27
• Revenue Growth: N/A
• EPS Growth: -77.17%
• Country: CA
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 63
• Industry: Biotechnology
• EPS (TTM): -0.37
• Shares Outstanding: 4,912,600
• 10 Day Avg. Volume: 11,713
• 30 Day Avg. Volume: 30,437
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• Price to Cash Flow (P/CF): -2.10
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Lexston Life Sciences Corp. is struggling financially with zero revenue and persistent losses. The technical indicators show positive momentum but suggest caution due to potential overbought conditions. Valuation concerns persist with a negative P/E ratio, and while corporate events suggest financial bolstering, they are more aligned with mining operations.

Lexston Life Sciences Corp. Business Overview & Revenue Model

Company Description

Lexston Life Sciences Corp. (LEXT) is a diversified life sciences company operating within the biotechnology and pharmaceutical sectors. The company focuses on the development and commercialization of innovative technologies and solutions aimed at enhancing human health and well-being. Lexston is involved in various stages of research, development, and production of biotechnology products that cater to the needs of the medical and healthcare industries.

How the Company Makes Money

Lexston Life Sciences Corp. generates revenue primarily through the development and commercialization of its proprietary biotechnological products and solutions. The company engages in research and development activities to create innovative health solutions, which are then licensed or directly sold to pharmaceutical companies, healthcare providers, and research institutions. Additionally, Lexston may enter into partnerships or collaborations with other entities in the life sciences sector to co-develop products or technologies, further expanding its revenue streams. These collaborations often involve licensing agreements, joint ventures, or research grants that contribute to the company's earnings. Key factors contributing to Lexston's revenue include successful product commercialization, strategic partnerships, and ongoing innovation in the biotechnology field.

Lexston Life Sciences Corp. Financial Statement Overview

Summary

Lexston Life Sciences Corp. faces significant financial challenges, including zero revenue and consistent losses. The balance sheet shows some stability with positive equity but increased debt levels. The cash flow is negative, highlighting reliance on financing and weak cash generation.

Income Statement

Lexston Life Sciences Corp. has consistently reported zero revenue over the past years, indicating challenges in generating sales. The company has negative gross profit, EBIT, and net income, reflecting operational inefficiencies and persistent losses. The absence of revenue growth further highlights the financial struggles.

Balance Sheet

The balance sheet shows a moderate level of stability, with a positive stockholders' equity. However, the total assets have been decreasing, and the company has recently taken on debt, increasing its financial risk. The equity ratio is diminishing, which could indicate growing leverage concerns.

Cash Flow

Lexston's cash flow statements reveal negative free cash flow, indicative of cash burn. The company relies heavily on financing cash flow to sustain operations. The negative operating cash flow and free cash flow to net income ratios suggest weak cash generation from core operations.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
0.00	0.00	0.00	361.01K	149.11K	0.00
	Gross Profit
-13.20K	-26.39K	-29.80K	241.49K	60.10K	0.00
	EBIT
-965.41K	-674.72K	-871.53K	-1.86M	-106.04K	-6.48K
	EBITDA
-1.35M	-648.32K	-841.73K	-1.89M	-479.82K	-6.48K
	Net Income Common Stockholders
-1.53M	-867.71K	-1.11M	-2.32M	-876.13K	-6.48K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
107.39K	390.40K	511.00K	590.49K	949.17K	170.76K
	Total Assets
475.92K	750.95K	814.30K	952.80K	1.10M	170.95K
	Total Debt
0.00	0.00	0.00	0.00	0.00	0.00
	Net Debt
-107.39K	-390.40K	-511.00K	-590.49K	-949.17K	-170.76K
	Total Liabilities
29.94K	39.87K	11.21K	79.09K	38.81K	1.96K
	Stockholders Equity
445.98K	711.08K	803.10K	873.71K	1.06M	168.99K
Cash Flow		Free Cash Flow
-1.47M	-723.16K	-987.74K	-1.40M	-608.63K	-4.71K
	Operating Cash Flow
-1.27M	-523.18K	-987.74K	-1.40M	-483.16K	-4.71K
	Investing Cash Flow
-199.99K	-199.99K	0.00	-109.97K	812.32K	0.00
	Financing Cash Flow
1.28M	602.57K	908.24K	1.15M	620.01K	175.47K

Lexston Life Sciences Corp. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.58
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LEXT, the sentiment is Positive. The current price of 0.58 is above the 20-day moving average (MA) of 0.28, above the 50-day MA of 0.23, and above the 200-day MA of 0.56, indicating a bullish trend. The MACD of 0.08 indicates Negative momentum. The RSI at 77.05 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:LEXT.

Lexston Life Sciences Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	46 Neutral	$2.64B	-3.89	-29.36%	3.33%	2.89%	-29.66%
LEXT	34 Underperform	C$2.85M	―	-238.21%	―	―	-77.17%

Lexston Life Sciences Corp. Corporate Events

Lexston Mining Corporation Secures $196,000 in Private Placement

Lexston Mining Corporation announced the successful closure of a non-brokered private placement, raising $196,000 through the issuance of 2,450,000 units. These funds will be used for general working capital, and the securities issued are subject to a four-month hold period. This move indicates Lexston’s ongoing efforts to bolster its financial position and support its mineral exploration projects in Canada.

Lexston Mining Corporation Launches Private Placement for Strategic Growth

Lexston Mining Corporation has announced a non-brokered private placement to raise up to $196,000 through the sale of 2,450,000 units priced at $0.08 each. The proceeds will be used for general working capital, with the issuance subject to Canadian Securities Exchange filing requirements and a four-month statutory hold period. This move could potentially strengthen Lexston’s financial position and support its ongoing mineral exploration projects, reinforcing its market presence.

Lexston Mining Corporation Cancels 442,500 Stock Options

Lexston Mining Corporation, a company known for its activities in the mining sector, has announced the cancellation of 442,500 incentive stock options previously granted to its directors, officers, employees, and consultants. This strategic move could be seen as an effort to optimize its capital structure and manage its stock option plan more effectively, potentially influencing the company’s future financial flexibility and stakeholder interests.

Lexston Mining Completes Share Consolidation to Optimize Share Structure

Lexston Mining Corporation has completed a share consolidation process, converting every ten pre-consolidation shares into one post-consolidation share, effectively reducing the number of issued and outstanding common shares from 49,126,000 to 4,912,600. This consolidation aims to streamline the company’s share structure, potentially enhancing its appeal to investors and improving its market positioning.

Lexston Mining Announces Share Consolidation to Streamline Operations

Lexston Mining Corporation has announced a consolidation of its common shares, reducing the number from 49,126,000 to approximately 4,912,600, with a ratio of ten pre-consolidated shares for one post-consolidated share. This move is pending acceptance from the Canadian Securities Exchange and aims to streamline the company’s share structure, potentially impacting its market operations and attractiveness to investors.

Lexston Mining Extends Key Property Agreements to Boost Exploration Efforts

Lexston Mining Corporation announced amendments to its Dory Property Option and Project 176 and Project Itza Property Option Agreements. These amendments extend deadlines for exploration expenditures and share issuance, allowing the company more time to fulfill requirements to earn full interests in these projects. This strategic move potentially enhances Lexston’s operational flexibility and strengthens its position in the mineral exploration industry.

Lexston Mining Delays Annual Meeting Amid Postal Strike

Lexston Mining Corporation has postponed its Annual General and Special Meeting due to delays caused by a Canada Post strike. The company has been granted a six-month extension to hold its annual meeting by June 30, 2025. Investors can access Lexston’s financial statements on SEDAR+, as the company continues its mineral exploration projects in Canada.